Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SCAN-MED. A/S. DENMARK Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   2.2% 3.5% 1.8% 1.7% 1.2% 1.4% 8.3% 8.1%   Credit score (0-100)   68 53 71 73 80 78 30 30   Credit rating   BBB BBB A A A A BB BB   Credit limit (kDKK)   0.3 0.0 6.5 27.4 399.0 103.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,082 6,303 7,527 14,067 10,762 10,313 0.0 0.0   EBITDA   180 215 1,150 6,028 3,297 2,653 0.0 0.0   EBIT   164 197 1,133 6,013 3,221 2,577 0.0 0.0   Pre-tax profit (PTP)   171.2 192.6 1,102.4 5,704.3 3,053.8 2,492.1 0.0 0.0   Net earnings   132.9 149.4 859.7 4,445.3 2,380.5 1,940.8 0.0 0.0   Pre-tax profit without non-rec. items   171 193 1,102 5,704 3,054 2,492 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   22.6 105 88.1 403 327 251 0.0 0.0   Shareholders equity total   6,334 6,483 7,194 15,089 13,469 13,410 10,804 10,804   Interest-bearing liabilities   1,115 194 2,044 179 2,013 132 0.0 0.0   Balance sheet total (assets)   9,942 12,409 13,473 26,426 21,374 19,277 10,804 10,804   Net Debt   -950 -1,639 295 -6,476 418 -846 -10,804 -10,804     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,082 6,303 7,527 14,067 10,762 10,313 0.0 0.0   Gross profit growth   -21.3% 3.6% 19.4% 86.9% -23.5% -4.2% -100.0% 0.0%   Employees   8 8 8 9 9 9 0 0   Employee growth %   0.0% 0.0% 0.0% 12.5% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9,942 12,409 13,473 26,426 21,374 19,277 10,804 10,804   Balance sheet change%   -18.7% 24.8% 8.6% 96.1% -19.1% -9.8% -44.0% 0.0%   Added value   179.7 214.6 1,150.2 6,028.0 3,236.3 2,652.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -31 65 -34 299 -152 -152 -251 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.7% 3.1% 15.1% 42.7% 29.9% 25.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.6% 1.8% 8.8% 30.1% 13.5% 12.7% 0.0% 0.0%   ROI %   2.3% 2.7% 13.6% 48.3% 20.9% 17.8% 0.0% 0.0%   ROE %   2.0% 2.3% 12.6% 39.9% 16.7% 14.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   63.9% 52.2% 55.7% 57.1% 63.0% 69.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -528.7% -763.9% 25.7% -107.4% 12.7% -31.9% 0.0% 0.0%   Gearing %   17.6% 3.0% 28.4% 1.2% 14.9% 1.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.7% 0.9% 2.7% 27.7% 15.2% 9.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.8 1.3 1.2 1.4 1.2 1.4 0.0 0.0   Current Ratio   2.9 2.2 2.3 2.3 2.7 3.3 0.0 0.0   Cash and cash equivalent   2,065.1 1,833.6 1,748.7 6,655.7 1,595.4 977.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   6,484.7 6,750.8 7,485.7 14,686.2 13,142.8 13,182.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   22 27 144 670 360 295 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   22 27 144 670 366 295 0 0   EBIT / employee   21 25 142 668 358 286 0 0   Net earnings / employee   17 19 107 494 264 216 0 0